GSEA revealed that malignant hallmarks of tumors, including pathways in cancer, WNT signaling pathway, transforming growth factor-β (TGF-β) signaling pathway and bladder cancer, were mainly enriched in the high risk subgroup (Figure 6B). The gene discussed is TGFB1; the disease is urinary bladder carcinoma.